Quadrant Capital »

Revance Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.3k 598 8.79
2023-09-30 $1.6k 143 11.48
2023-06-30 $4.2k 165 25.32
2023-03-31 $5.1k 158 32.22
2022-12-31 $3.0k 160 18.46
2022-09-30 $6.0k 216 27.78
2022-06-30 $3.0k 216 13.89
2022-03-31 $5.0k 257 19.46
2021-12-31 $5.0k 317 15.77
2021-09-30 $3.0k 113 26.55
2021-06-30 $3.0k 108 27.78
2021-03-31 $6.0k 218 27.52
2020-12-31 $6.0k 218 27.52
2020-09-30 $5.0k 218 22.94
2020-06-30 $5.0k 218 22.94
2020-03-31 $128k 7.0k 18.18
2019-12-31 $64k 7.0k 9.09
2019-09-30 $64k 7.0k 9.09
2019-03-31 $23k 1.5k 15.56
2018-12-31 $2.0k 103 19.42
2018-09-30 $2.0k 103 19.42
2018-06-30 $2.0k 103 19.42
2018-03-31 $3.0k 103 29.13
2017-12-31 $3.0k 103 29.13
2017-09-30 $2.0k 103 19.42
2017-06-30 $2.0k 103 19.42
2017-03-31 $2.0k 103 19.42